IPACK Block for Motor-Sparing Knee Pain Relief

The IPACK block is an ultrasound-guided regional anesthesia technique that deposits local anesthetic in the space between the popliteal artery and the back of the knee joint capsule, targeting the sensory nerves responsible for posterior knee pain after surgery. First introduced at a professional meeting in 2012, it was designed specifically to relieve pain behind the knee without weakening the leg muscles needed for walking, a problem that older nerve-blocking approaches often caused. The technique has gained traction in knee replacement surgery and is now being studied for other procedures, though its benefits are more nuanced than the early enthusiasm suggested.

What the Block Actually Targets

Most pain after knee replacement comes from two zones: the front and inner side of the knee, and the back. The front is well served by the adductor canal block, a separate technique that numbs sensory nerves running along the inner thigh. The back of the knee, however, is supplied by a tangle of small articular nerve branches that travel alongside blood vessels behind the joint capsule. These branches are difficult to reach individually, and traditional approaches like a full sciatic nerve block numb the entire lower leg, including the muscles that control the foot and ankle.

The IPACK block sidesteps that problem by placing local anesthetic into a specific tissue plane rather than around a named nerve trunk. A cadaver study found that the injected fluid consistently surrounded the middle genicular artery, a vessel that runs close to the small sensory nerves supplying the posterior knee joint. Because sensory nerves tend to travel alongside arteries in predictable patterns, bathing the area around this artery appears to be what produces pain relief.¹ Additional cadaveric work confirmed that the injectate spreads across the posterior capsule in a way consistent with blocking the articular branches that innervate the back of the joint.²

Why Preserving Motor Function Matters

Getting out of bed and walking soon after knee replacement is one of the strongest predictors of a smooth recovery. Physiotherapists often want patients up within hours of surgery, and that requires a leg that can bear weight. A sciatic nerve block delivers excellent pain control behind the knee, but it also shuts down the muscles that lift the foot and stabilize the ankle. The result, known as foot drop, makes early walking difficult or dangerous and can delay discharge.

A randomized trial comparing the IPACK block to a tibial nerve block found that both IPACK groups preserved motor function far better. No patient in the group receiving a more distal IPACK injection experienced complete sensorimotor blockade, while the tibial nerve block group had substantially higher rates of both foot drop and impaired tibial nerve motor function.³ A separate retrospective comparison against a full sciatic nerve block reached a similar conclusion: the sciatic block produced lower pain scores during movement, but at the cost of significantly more motor blockade, whereas the IPACK group was better positioned for early mobilization.⁴

This trade-off is the core pitch of the IPACK block: it may not match a full sciatic block for raw pain scores, but it lets patients stand up and walk sooner because the muscles in the lower leg keep working.

How Well Does It Actually Control Pain?

The evidence on pain relief is real but modest, and it depends on what the IPACK block is being compared against. A meta-analysis of randomized controlled trials found that adding the IPACK block to a multimodal pain regimen lowered pain scores during walking by roughly half a point on a standard ten-point scale and reduced overall oral morphine use by a small amount. The benefit was most pronounced within the first twelve hours after surgery and, interestingly, also appeared at the one-week mark.⁵

Not every study is so optimistic. One trial that added the IPACK to a continuous adductor canal block found that pain scores improved at twelve hours but the advantage disappeared at later time points, and opioid use was not significantly reduced.⁶ A systematic review of eight randomized trials involving nearly 800 patients reached a mixed verdict: movement pain scores in the recovery room were lower with the IPACK block in the majority of studies, but pain scores after twenty-four hours were similar or sometimes even higher, and opioid consumption was comparable in most trials. The same review noted high-quality evidence that complication rates and walking distances did not differ between IPACK and non-IPACK groups.⁷

The honest read of the literature is that the IPACK block provides a short window of better pain control behind the knee, mostly in the first half-day after surgery, but its impact on overall opioid use and longer-term pain is less consistent. Whether that short window matters depends on the institution’s recovery protocols and what other pain strategies are already in place.

Pairing with the Adductor Canal Block

In practice, the IPACK block is almost never used alone. It targets the back of the knee, which means the front and inner side remain uncovered. The most common pairing is with an adductor canal block, which numbs the saphenous nerve and addresses anterior knee pain while sparing the quadriceps muscle. Together, the two blocks are designed to provide pain coverage around the entire knee without significant motor impairment.⁸

A prospective, double-blind randomized trial tested three groups: adductor canal block plus IPACK, adductor canal block plus periarticular injection, and adductor canal block alone. The combined nerve block group had the lowest pain scores within the first eight hours, both at rest and with knee bending. From twelve to twenty-four hours, the adductor-canal-only group had the highest pain scores while the other two groups were similar. After twenty-four hours, the differences between all three groups faded. The adductor-canal-only group also consumed the most opioids during hospitalization.⁹

This pattern keeps showing up: the IPACK block’s main contribution is in the early postoperative hours. By the second day, other pain-management strategies tend to catch up. That does not make the early benefit trivial, though. The first night after knee replacement is often the worst, and better pain control during that window can make the difference between a patient who participates in physical therapy the next morning and one who refuses to move.

IPACK Versus Periarticular Injection

Many surgeons already inject a cocktail of local anesthetic, anti-inflammatory medication, and sometimes other agents directly into the tissues around the knee at the end of surgery. This periarticular injection is simple, adds no extra procedure time, and does not require an ultrasound machine or a trained regional anesthesiologist. Naturally, the question becomes whether adding nerve blocks on top of that actually helps.

One randomized comparison of adductor canal block plus IPACK versus periarticular injection found that pain scores and morphine requirements were not different during the first forty-eight hours. At seventy-two hours, the nerve block group actually reported slightly higher pain scores. Knee flexion angle, ability to perform a straight-leg raise, nausea, and length of hospital stay were all similar.¹⁰ Another trial found that a continuous adductor canal block alone produced lower pain scores and less opioid consumption than a single-shot adductor canal block combined with IPACK, suggesting that prolonging the duration of the front-of-knee block may matter more than adding a separate posterior block.¹¹

These findings do not mean the IPACK block is useless, but they do suggest that it is not automatically superior to simpler alternatives. Periarticular injection already covers the posterior capsule to some extent, and a continuous catheter can extend the duration of an adductor canal block well beyond what a single shot provides. Where the IPACK block shines is in protocols that rely on single-injection nerve blocks and need posterior coverage without motor compromise. In institutions that already use robust periarticular cocktails or continuous catheter techniques, the marginal benefit of adding IPACK may be small.

Extending the Block with Dexamethasone

One of the practical limitations of any single-shot nerve block is that it wears off. A typical IPACK block using ropivacaine or bupivacaine lasts somewhere around eight to twelve hours, which often means pain returns in the middle of the first night. Adding dexamethasone, a steroid, to the local anesthetic mixture has been studied as a way to stretch that duration.

A randomized trial found that patients who received dexamethasone alongside the local anesthetic experienced pain relief lasting roughly sixteen hours compared to about nine hours without it. Over forty-eight hours, the dexamethasone group used about half as much opioid, and only a fifth of patients in that group needed any opioid at all, compared to half in the control group. Motor function and adverse event rates were not different between groups.¹² A longer-term study followed patients for a full year and found that adding dexamethasone not only improved immediate pain control but also appeared to reduce the incidence of rebound pain (the flare that occurs when a block wears off) and chronic pain after surgery.¹³

If these results hold up in larger trials, the dexamethasone addition could address the main criticism of the IPACK block: that its benefit is real but too brief to meaningfully change the overall recovery trajectory.

Mobilization and Discharge

Pain control is not the only outcome that matters. How quickly a patient gets out of bed, how far they walk, and when they go home are all tracked in modern knee replacement programs. A systematic review and meta-analysis of randomized controlled trials found that range of motion and walking distance were both significantly greater in IPACK groups overall.¹⁴ One randomized trial reported that patients receiving the IPACK plus adductor canal block combination had shorter times to first mobilization and shorter hospital stays than those receiving an adductor canal block alone or a periarticular injection with an adductor canal block.¹⁵

That said, the systematic review of eight RCTs mentioned earlier found no difference in gait distance across four studies that measured it. The picture that emerges is institution-dependent: in programs with aggressive early mobilization goals, the motor-sparing quality of the IPACK block may translate into faster first steps, but the overall distance walked during the hospital stay does not always end up different.

Beyond Knee Replacement

The IPACK block was developed for total knee arthroplasty, but researchers have begun testing it in other knee surgeries, particularly anterior cruciate ligament reconstruction. A randomized trial in adults undergoing ACL reconstruction with a bone-patellar tendon-bone graft found that adding the IPACK block to an adductor canal block roughly halved opioid use over the first three days and produced lower pain scores and higher patient satisfaction on the first postoperative day compared to the adductor canal block alone.¹⁶

The story in younger patients looks different. A study of adolescents undergoing ACL reconstruction with hamstring grafts found no benefit from adding IPACK to the adductor canal block: opioid use and pain scores were similar whether the patients received the combination block, an adductor canal block alone, or a local injection at the surgical site. The authors concluded that adding the IPACK block is not recommended for this population.¹⁷ The difference may relate to graft type (bone-patellar tendon-bone grafts typically produce more posterior knee pain than hamstring grafts), patient age, or the generally lower opioid use in adolescents to begin with. Either way, the results are a reminder that a block targeting the back of the knee only helps when the back of the knee is a major source of pain.

Dosing and Local Anesthetic Choices

A typical IPACK block uses about 20 milliliters of local anesthetic solution, with a common range of 15 to 25 milliliters. The most frequently used drugs are ropivacaine at 0.2 percent or bupivacaine at 0.25 percent, sometimes with epinephrine added to slow absorption. Some centers use a mixture that includes liposomal bupivacaine, a long-acting formulation, blended with standard bupivacaine.¹⁸

Whether higher concentrations or larger volumes produce better results remains an open question. A prospective randomized trial comparing different local anesthetic doses found that mid-range doses produced the best balance of pain scores and opioid reduction, while the lowest-dose group had worse pain control and more nausea and vomiting at later time points. Patient and surgeon satisfaction were also lower in the lowest-dose group.¹⁹ The sweet spot appears to be somewhere in the middle of the range, enough to adequately fill the tissue plane without wasting drug or increasing the risk of local anesthetic toxicity.

Safety Profile

The safety record of the IPACK block is reassuringly clean across the published literature. A narrative review noted that foot drop was uncommon with the IPACK block, and compared to tibial nerve blocks, the IPACK block reduced the occurrence of foot drop while increasing the proportion of patients discharged by the third postoperative day.²⁰ Across the randomized trials, no procedure-related complications have been identified at rates above background levels. Because the needle tip stays in a tissue plane rather than targeting a nerve trunk directly, the risk of nerve injury is lower than with more traditional approaches, and vascular puncture of the popliteal artery is avoidable under ultrasound guidance.

The main “risk” is not a safety event but a practical one: getting the injection into the wrong tissue plane, which diminishes the block’s effectiveness without causing harm. Correct ultrasound identification of the popliteal artery and the posterior capsule requires some training, and the block is less straightforward to perform than a periarticular injection that the surgeon does directly at the end of the case.

Cost Considerations

Regional nerve blocks add procedural cost, and that is worth acknowledging. A cost analysis found that the mean total cost for a motor-sparing block protocol (which includes blocks like the IPACK and adductor canal combination) was roughly $1,960 per patient, compared to about $1,616 for periarticular injection alone. The extra cost came from the block procedure itself, including anesthesiologist time, ultrasound use, and supplies. Postoperative inpatient costs, including length of stay and total opioid use, did not differ significantly between the two groups.²¹

The extra few hundred dollars per case might be justified if the block reliably shortened hospital stays or reduced complications, but the evidence on those downstream savings is mixed. In institutions where the IPACK block speeds mobilization enough to move patients through faster, the math could work out. In programs already achieving rapid discharge with simpler methods, the added cost may not pay for itself. The decision tends to come down to local practice patterns: how the anesthesia team is structured, what the surgeon already does intraoperatively, and how aggressively the institution pursues same-day or next-day discharge.

When the IPACK Block Makes the Most Sense

Given the mixed evidence, the clearest case for the IPACK block is in a patient undergoing total knee replacement at an institution that uses single-shot adductor canal blocks and wants posterior knee coverage without risking motor weakness. The combination addresses both anterior and posterior knee pain, preserves the ability to walk, and delivers its strongest benefit in the critical first twelve hours. For patients at high risk of opioid-related complications or those in enhanced recovery programs that prioritize very early ambulation, that short window of better posterior pain control and preserved muscle strength can meaningfully improve the first day of recovery.

The case weakens when the institution already uses a robust periarticular injection cocktail, a continuous adductor canal catheter, or a multimodal protocol with adjuvants like dexamethasone baked in from the start. It also weakens for surgeries where the posterior knee is not a primary pain source, such as certain types of ligament reconstruction in younger patients. The IPACK block is a useful tool, but its value depends heavily on what else is in the toolbox.